H.R. 8716

H.R. 8716: To amend titles XIX and XXI of the Social Security Act, title XXVII of the Public Health Service Act, the Employee Retirement Security Act of 1974, and the Internal Revenue Code of 1986 to require coverage of self-measured blood pressure monit

Introduced Nikema Williams (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 8716 aims to amend several existing laws to require health insurance plans, including Medicaid and Medicare, to cover the costs of self-measured blood pressure monitoring devices. This legislation is intended to improve hypertension management by making it easier for patients to monitor their blood pressure at home.

Positive Media Summary

Supporters of H.R. 8716 have praised the bill for promoting better health outcomes and empowering patients to take control of their hypertension management. Media outlets have highlighted the potential for reduced healthcare costs and improved quality of life for those with high blood pressure, emphasizing the importance of accessible health monitoring tools.

Negative Media Summary

Critics of H.R. 8716 have raised concerns about the potential costs associated with requiring insurance coverage for self-measured blood pressure monitors. Some media reports suggest that this mandate could lead to increased premiums for consumers and question the necessity of such coverage when other monitoring options are available.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of H.R. 8716, sponsored by Nikema Williams, reveals no direct industry overlaps between the bill's subject matter—requiring coverage of self-measured blood pressure monitors—and the sponsor's top donor industries. While there is lobbying activity in the policy area related to health and medical devices, the specific amounts and connections to the bill are largely undisclosed, making it difficult to ascertain direct conflicts of interest. The only disclosed lobbying amount is from DIRSHU INTERNATIONAL, which contributed $100,000, but it does not indicate a direct financial interest in the bill's provisions. Therefore, the risk of conflict appears low, as there are no clear financial incentives that could influence the sponsor's legislative actions.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
DIRSHU INTERNATIONAL MERKAVA STRATEGIES CORPORATION $100,000
CEO WORKS SAUNDERS GLOBAL DIPLOMACY $45,000
KAZI IG SAUNDERS GLOBAL DIPLOMACY $15,000
SOUTHERN FOLGER CONTRACTING BBT STRATEGIES LLC $10,000
WATERFRONT GLOBAL BBT STRATEGIES LLC $5,200
DIGITALEUROPE VIVID STRATEGIES LLC undisclosed
INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE MERKAVA STRATEGIES CORPORATION undisclosed
DR. STEPHEN SOLOWAY MERKAVA STRATEGIES CORPORATION undisclosed
ONE ISRAEL FUND MERKAVA STRATEGIES CORPORATION undisclosed
HEMOGLOBIN OXYGEN THERAPEUTICS MERKAVA STRATEGIES CORPORATION undisclosed
ATAOLLAH AMINPOUR MERKAVA STRATEGIES CORPORATION undisclosed
HERSEL NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MORAD BEN NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MARK SCOTT MERKAVA STRATEGIES CORPORATION undisclosed
BORIS MINTS MERKAVA STRATEGIES CORPORATION undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Nikema Williams, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us